Developmental Delay Disorder Clinical Trials

7 recruitingLast updated: May 21, 2026

There are 7 actively recruiting developmental delay disorder clinical trials across 3 countries. Studies span Early Phase 1, Not Applicable. Top locations include Brest, France, Columbia, Missouri, United States, Fort Myers, Florida, United States. Updated daily from ClinicalTrials.gov.


Developmental Delay Disorder Trials at a Glance

7 actively recruiting trials for developmental delay disorder are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Early Phase 1 with 2 trials, with the heaviest enrollment activity in Brest, Columbia, and Fort Myers. Lead sponsors running developmental delay disorder studies include Healing Hope International, Hospices Civils de Lyon, and Florida Gulf Coast University.

Browse developmental delay disorder trials by phase

About Developmental Delay Disorder Clinical Trials

Looking for clinical trials for Developmental Delay Disorder? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Developmental Delay Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Developmental Delay Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Behavioral Parent Training to Address Early Childhood Disruptive Behavior Using the Helping Our Toddlers, Developing Our Children's Skills (HOT DOCS) Program and the Developing Our Children's Skills Kindergarten-5th Grade (DOCS K-5) Program

Developmental DisabilityDisruptive BehaviorDevelopmental Delay Disorder+1 more
University of South Florida800 enrolled1 locationNCT07505381
Recruiting

Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders

Traumatic Brain Injury (TBI)Hypoxic-ischemic encephalopathy (HIE)Williams Syndrome+20 more
Healing Hope International100 enrolled1 locationNCT07493096
Recruiting
Not Applicable

Repetitive Transcranial Magnetic Stimulation Combined With Language Training for Language Disorders in Children With Global Developmental Delay

Global developmental delayRepetitive Transcranial Magnetic Stimulation (rTMS)Developmental Delay Disorder+1 more
Xiangya Hospital of Central South University50 enrolled1 locationNCT07369960
Recruiting

Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)

seizureEpilepsyGenetic Mutations+6 more
University of Missouri-Columbia100 enrolled1 locationNCT07329257
Recruiting

Genotype/Phenotype Correlation of MORC2 Mutations

Impaired growthCharcot-Marie-Tooth diseaseDevelopmental Delay Disorder+2 more
Hospices Civils de Lyon45 enrolled12 locationsNCT07038239
Recruiting
Early Phase 1

Clinical Trial of the Dual Vector Base Editor for the Treatment of the CHD3-R1025W Mutation

Rare DiseasesIntellectual DisabilityDevelopmental Delay Disorder
Yongguo Yu1 enrolled1 locationNCT06860672
Recruiting
Early Phase 1

Promoting Playfulness

Developmental Delay Disorder
Florida Gulf Coast University40 enrolled1 locationNCT06625255